COPD and smoking

COPD and smoking

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
David M.G. Halpin, Claus F. Vogelmeier, Karen Mezzi, Pritam Gupta, Konstantinos Kostikas, Jadwiga A. Wedzicha

ERJ Open Research Jan 2021, 7 (1) 00816-2020; DOI: 10.1183/23120541.00816-2020
Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts
Eskandarain Shafuddin, Sarah M. Fairweather, Catherina L. Chang, Christine Tuffery, Robert J. Hancox

ERJ Open Research Jan 2021, 7 (1) 00531-2020; DOI: 10.1183/23120541.00531-2020
Predictors of pulmonary rehabilitation completion in the UK
Philip W. Stone, Katherine Hickman, Michael C. Steiner, C. Michael Roberts, Jennifer K. Quint, Sally J. Singh

ERJ Open Research Jan 2021, 7 (1) 00509-2020; DOI: 10.1183/23120541.00509-2020
Treatable cardiac disease in hospitalised COPD exacerbations
Paul Leong, Martin I. MacDonald, Paul T. King, Christian R. Osadnik, Brian S. Ko, Shane A. Landry, Kais Hamza, Ahilan Kugenasan, John M. Troupis, Philip G. Bardin

ERJ Open Research Jan 2021, 7 (1) 00756-2020; DOI: 10.1183/23120541.00756-2020
Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses
Balázs Csoma, András Bikov, Ferenc Tóth, György Losonczy, Veronika Müller, Zsófia Lázár

ERJ Open Research Jan 2021, 7 (1) 00543-2020; DOI: 10.1183/23120541.00543-2020
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective
Dominic L. Sykes, Shoaib Faruqi, Luke Holdsworth, Michael G. Crooks

ERJ Open Research Jan 2021, 7 (1) 00822-2020; DOI: 10.1183/23120541.00822-2020
Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
Niklas Karlsson, Mark J. Atkinson, Hana Müllerová, Marianna Alacqua, Christina Keen, Rod Hughes, Christer Janson, Barry Make, David Price, Helen K. Reddel

ERJ Open Research Jan 2021, 7 (1) 00828-2020; DOI: 10.1183/23120541.00828-2020
Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe

ERJ Open Research Jan 2021, 7 (1) 00394-2020; DOI: 10.1183/23120541.00394-2020
Severe outcomes of COVID-19 among patients with COPD and asthma
Erik Soeren Halvard Hansen, Amalie Lykkemark Moeller, Vibeke Backer, Mikkel Porsborg Andersen, Lars Kober, Kristian Kragholm, Christian Torp-Pedersen

ERJ Open Research Jan 2021, 7 (1) 00594-2020; DOI: 10.1183/23120541.00594-2020
Endoscopic lung volume reduction with endobronchial valves in very low D_LCO patients: results from the German Registry – Lungenemphysemregister e.V.
Pavlina Lenga, Christoph Ruwwe-Glösenkamp, Christian Grah, Joachim Pfannschmidt, Jens Rückert, Stephan Eggeling, Sven Gläser, Bernd Schmidt, Paul Schneider, Sylke Kurz, Gunda Leschber, Andreas Gebhardt, Birgit Becke, Olaf Schega, Jakob Borchardt, Ralf-Harto Hübner

ERJ Open Research Jan 2021, 7 (1) 00449-2020; DOI: 10.1183/23120541.00449-2020

Main menu

User menu

Search

COPD and smoking

Pages

Contact us